CADL earnings: a positive outcome, +6.3%

On April 25, 2024, Candel Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +6.3% in the window around the event. It had already run +271.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.